Sign In
Buy STAA
$28.26
-0.230 (-0.81%)
At Close: Jun 03, 2026
Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms
03:47pm, Wednesday, 03'rd Dec 2025
California-based Palo Alto Investors sold 791,879 shares of STAAR Surgical Company in the third quarter, leading its position value to fall by $13.3 million. The transaction represented approximately
Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors
04:14pm, Tuesday, 02'nd Dec 2025
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today announced that it is well along in the multi-step and time-consuming process that is requir
Atika Capital Management LLC Takes $275,000 Position in STAAR Surgical Company $STAA
03:54am, Thursday, 27'th Nov 2025
Atika Capital Management LLC purchased a new stake in STAAR Surgical Company (NASDAQ: STAA) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm pur
STAAR Surgical Company (NASDAQ:STAA) Receives Consensus Rating of “Reduce” from Analysts
02:12am, Thursday, 27'th Nov 2025
Shares of STAAR Surgical Company (NASDAQ: STAA - Get Free Report) have been given an average recommendation of "Reduce" by the eleven analysts that are presently covering the firm, MarketBeat.com repo
Market Today: Stocks Rise on Fed Cut Bets; Alphabet, Apple Hit Records
06:00pm, Tuesday, 25'th Nov 2025
Guru Stock PicksJefferies Group has made the following transactions:Reduce in CLDX by 12.28%Sold out in UNFIAdd in SMH by 25.28%New position in XNCRT Rowe Price
Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process
08:00am, Monday, 10'th Nov 2025
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today commented on the recent filing of amendments to the merger agreement in connection with the
STAAR Surgical Announces Amendments to Alcon Merger Agreement
10:10am, Friday, 07'th Nov 2025
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
Yunqi Capital Applauds STAAR Surgical's Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated
06:21am, Thursday, 06'th Nov 2025
HONG KONG--(BUSINESS WIRE)--Yunqi Capital Applauds STAAR Surgical's Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated.
STAAR Surgical Reports Third Quarter 2025 Results
04:01pm, Wednesday, 05'th Nov 2025
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects
11:52am, Tuesday, 04'th Nov 2025
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the investor presentation issued by Alcon Inc. (“Alcon”) (NYSE: ALC) regardi
Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon
12:00pm, Friday, 31'st Oct 2025
HONG KONG--(BUSINESS WIRE)--Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Com
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) announced that, in light of ongoing discussions with Alcon (SIX/N
HONG KONG--(BUSINESS WIRE)--Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Com
Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction
08:00am, Friday, 24'th Oct 2025
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which owns 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “
Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders
12:09pm, Thursday, 23'rd Oct 2025
GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA), the manufact
